These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24387687)

  • 1. Relationship between cognitive dysfunction, gait, and motor impairment in children and adolescents with neurofibromatosis type 1.
    Champion JA; Rose KJ; Payne JM; Burns J; North KN
    Dev Med Child Neurol; 2014 May; 56(5):468-74. PubMed ID: 24387687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive control in adolescents with neurofibromatosis type 1.
    Rowbotham I; Pit-ten Cate IM; Sonuga-Barke EJ; Huijbregts SC
    Neuropsychology; 2009 Jan; 23(1):50-60. PubMed ID: 19210032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological profile in adults with neurofibromatosis type 1 compared to a control group.
    Descheemaeker MJ; Plasschaert E; Frijns JP; Legius E
    J Intellect Disabil Res; 2013 Sep; 57(9):874-86. PubMed ID: 23095048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does attention-deficit-hyperactivity disorder exacerbate executive dysfunction in children with neurofibromatosis type 1?
    Payne JM; Arnold SS; Pride NA; North KN
    Dev Med Child Neurol; 2012 Oct; 54(10):898-904. PubMed ID: 22845611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.
    Hyman SL; Shores A; North KN
    Neurology; 2005 Oct; 65(7):1037-44. PubMed ID: 16217056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive dysfunction, gait, and motor impairment in neurofibromatosis type 1.
    Johnson B
    Dev Med Child Neurol; 2014 May; 56(5):415. PubMed ID: 24621056
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cognitive dysfunction and emotional disturbances in children with neurofibromatosis type one (Recklinghausen's disease). Review of the literature].
    Trzcińska M; Borkowska A
    Psychiatr Pol; 2005; 39(2):371-81. PubMed ID: 15881631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Executive dysfunction in children with neurofibromatosis type 1: a study of action planning.
    Roy A; Roulin JL; Charbonnier V; Allain P; Fasotti L; Barbarot S; Stalder JF; Terrien A; Le Gall D
    J Int Neuropsychol Soc; 2010 Nov; 16(6):1056-63. PubMed ID: 20682087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motor impairment in children with Neurofibromatosis type 1: Effect of the comorbidity with language disorders.
    Iannuzzi S; Albaret JM; Chignac C; Faure-Marie N; Barry I; Karsenty C; Chaix Y
    Brain Dev; 2016 Feb; 38(2):181-7. PubMed ID: 26321374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cognitive impairment in adults with neurofibromatosis type 1].
    Uttner I; Wahlländer-Danek U; Danek A
    Fortschr Neurol Psychiatr; 2003 Mar; 71(3):157-62. PubMed ID: 12624853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corpus callosum morphology and its relationship to cognitive function in neurofibromatosis type 1.
    Pride N; Payne JM; Webster R; Shores EA; Rae C; North KN
    J Child Neurol; 2010 Jul; 25(7):834-41. PubMed ID: 20142468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The handwriting performance of children with NF1.
    Gilboa Y; Josman N; Fattal-Valevski A; Toledano-Alhadef H; Rosenblum S
    Res Dev Disabil; 2010; 31(4):929-35. PubMed ID: 20392595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern of motor and cognitive deficits in detoxified alcoholic men.
    Sullivan EV; Rosenbloom MJ; Pfefferbaum A
    Alcohol Clin Exp Res; 2000 May; 24(5):611-21. PubMed ID: 10832902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Underlying mechanisms of writing difficulties among children with neurofibromatosis type 1.
    Gilboa Y; Josman N; Fattal-Valevski A; Toledano-Alhadef H; Rosenblum S
    Res Dev Disabil; 2014 Jun; 35(6):1310-6. PubMed ID: 24691356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relation between cognition and motor dysfunction in drug-naive newly diagnosed patients with Parkinson's disease.
    Domellöf ME; Elgh E; Forsgren L
    Mov Disord; 2011 Oct; 26(12):2183-9. PubMed ID: 21661051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Social functioning in adults with neurofibromatosis type 1.
    Pride NA; Crawford H; Payne JM; North KN
    Res Dev Disabil; 2013 Oct; 34(10):3393-9. PubMed ID: 23911645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cognitive profile of preschool-aged children with neurofibromatosis type 1.
    Sangster J; Shores EA; Watt S; North KN
    Child Neuropsychol; 2011; 17(1):1-16. PubMed ID: 20503125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of ADHD on the cognitive and academic functioning of children with NF1.
    Pride NA; Payne JM; North KN
    Dev Neuropsychol; 2012; 37(7):590-600. PubMed ID: 23066937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual task performance in Parkinson's disease: a sensitive predictor of impairment and disability.
    Fuller RL; Van Winkle EP; Anderson KE; Gruber-Baldini AL; Hill T; Zampieri C; Weiner WJ; Shulman LM
    Parkinsonism Relat Disord; 2013 Mar; 19(3):325-8. PubMed ID: 23265679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International collaborative study of intracytoplasmic sperm injection-conceived, in vitro fertilization-conceived, and naturally conceived 5-year-old child outcomes: cognitive and motor assessments.
    Ponjaert-Kristoffersen I; Bonduelle M; Barnes J; Nekkebroeck J; Loft A; Wennerholm UB; Tarlatzis BC; Peters C; Hagberg BS; Berner A; Sutcliffe AG
    Pediatrics; 2005 Mar; 115(3):e283-9. PubMed ID: 15741353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.